Individualized Treatment Planning in Oncology: Role of PET and Radiolabelled Anticancer Drugs in Predicting Tumour Resistance

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	2914-2931
Journal	Current pharmaceutical design
Volume	14
Issue number	28
DOIs	https://doi.org/10.2174/138161208786404344
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{e39c11e7c717446db677ed70e792f94b,

title = "Individualized Treatment Planning in Oncology: Role of PET and Radiolabelled Anticancer Drugs in Predicting Tumour Resistance",

author = "\{van der Veldt\}, A.A.M. and G. Luurtsema and J.M. Lubberink and A.A. Lammertsma and N.H. Hendrikse",

year = "2008",

doi = "10.2174/138161208786404344",

language = "Undefined/Unknown",

volume = "14",

pages = "2914--2931",

journal = "Current pharmaceutical design",

issn = "1381-6128",

publisher = "Bentham Science Publishers B.V.",

number = "28",

}

TY - JOUR

T1 - Individualized Treatment Planning in Oncology: Role of PET and Radiolabelled Anticancer Drugs in Predicting Tumour Resistance

AU - van der Veldt, A.A.M.

AU - Luurtsema, G.

AU - Lubberink, J.M.

AU - Lammertsma, A.A.

AU - Hendrikse, N.H.

PY - 2008

Y1 - 2008

U2 - 10.2174/138161208786404344

DO - 10.2174/138161208786404344

M3 - Article

SN - 1381-6128

VL - 14

SP - 2914

EP - 2931

JO - Current pharmaceutical design

JF - Current pharmaceutical design

IS - 28

ER -